Brief: EQL Pharma Q2 EBITDA Up At SEK 2.3 Million

EQL Pharma AB

11/11/2019 14:19

Nov 11 (Reuters) - EQL Pharma AB  EQL.TE :
    * CONSOLIDATED SALES FOR Q2 AMOUNTED TO SEK 17.9 (13.3) MILLION, AN INCREASE OF 35%
    * JULY SEPTEMBER EBITDA AMOUNTED TO SEK 2.3 (2.1) MILLION
    * ESTIMATES SALES FOR FY 2019/2010 WILL INCREASE BY AROUND 30% COMPARED WITH PREVIOUS FY,
EXPECTS
EBITDA TO GROW AT SIMILAR RATE

Source text for Eikon:  ID:nWkrKxD98 
Further company coverage:  EQL.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))